Daxor Corporation (NYSE Amex: DXR) is a New York-based company headquartered at 350 Fifth Avenue, Suite 7120, New York, New York 10118, as of the 10-K filed March 28, 2012 for fiscal year ended December 31, 2011. The filing excerpts provided do not contain sufficient detail to characterize Daxor's core business activity, revenue model, segment financials, competitive position, or key products beyond its exchange listing and corporate address. Based solely on the available filing excerpts, a complete canonical business description cannot be constructed without risk of introducing unsupported facts.
Source: SEC 10-K, filed 2012-03-28
Industry: UNKNOWN Peers: Abbott Laboratories Cytosorbents Corp Eargo, Inc. enVVeno Medical Corp Kewaunee Scientific Corp Lucid Diagnostics Inc Neuronetics Inc Pro-Dex Inc
Loading...
